Cargando…

Seroprevalence of SARS-CoV-2 Antibodies among Vaccinated and Non-Vaccinated Adults in the West Bank: Results of a Repeated Cross-Sectional Study

Seroprevalence studies provide an accurate measure of SARS-CoV-2 spread at a population level and the number of undiagnosed individuals. Repeated cross-sectional sero-studies are encouraged to monitor the spread of the virus. The aim of this study is to assess the seroprevalence rate among a random...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awartani, Faisal, Qutob, Nouar Mohammad, Asia, Mohammad Rajab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414774/ https://www.ncbi.nlm.nih.gov/pubmed/36016220 http://dx.doi.org/10.3390/vaccines10081332

Ejemplares similares

Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study
por: Qutob, Nouar, et al.
Publicado: (2021)

Knowledge, attitudes and practices (KAP) towards COVID-19 among Palestinians during the COVID-19 outbreak: A cross-sectional survey
por: Qutob, Nouar, et al.
Publicado: (2021)

Effects of SARS-CoV-2 vaccination on blood donation and blood banks in India
por: Hunain, Reem, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians
por: Onifade, Abdulfattah Adekunle, et al.
Publicado: (2023)

Prevalence and sociodemographic correlates of stunting, underweight, and overweight among Palestinian school adolescents (13-15 years) in two major governorates in the West Bank
por: Mikki, Nahed, et al.
Publicado: (2009)

Seroprevalence of SARS-CoV-2 antibodies in vaccinated healthcare workers in Marrakech (Morocco)
por: Ben Houmich, Taoufik, et al.
Publicado: (2022)

SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa
por: Abdullahi, Adam, et al.
Publicado: (2022)

Seroprevalence and SARS-CoV-2 antibodies distribution in Portugal following mass vaccination campaign
por: Kislaya, I, et al.
Publicado: (2022)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 Antibodies Among Blood Donors in Malaysia During the Pre-Vaccination Period
por: Shukri, A.M.A., et al.
Publicado: (2022)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Defining Antibody Seroprevalence and Duration of Humoral Responses to SARS-CoV-2 Infection and/or Vaccination in a Greek Community
por: Kotsiou, Ourania S., et al.
Publicado: (2021)

Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile
por: Aguilera, Ximena, et al.
Publicado: (2022)

Prevalence and risk factors of obesity and hypertension among students at a central university in the West Bank
por: Tayem, Yasin I., et al.
Publicado: (2012)

Seroprevalence of Antitransglutaminase and Antiendomysium Antibodies in Adult Colombian Blood Bank Donors
por: Paredes-Echeverri, Sara, et al.
Publicado: (2020)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination
por: Horndler, Lydia, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis
por: Wang, Peng, et al.
Publicado: (2022)

The Seroprevalence of SARS-CoV-2 Antibodies among HealthCare Workers in University Hospital in Krakow before the Era of Vaccination
por: Żółtowska, Barbara, et al.
Publicado: (2022)

Influenza Vaccination Coverage and (SARS-CoV-2) Seroprevalance in a Fire Department
por: Caban-Martinez, A.J., et al.
Publicado: (2020)

Seroprevalence of antibodies to astrovirus in chickens in Grenada, West Indies
por: Sharma, Ravindra Nath, et al.
Publicado: (2017)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Kinetics and seroprevalence of SARS-CoV-2 antibodies in children
por: Roarty, Cathal, et al.
Publicado: (2021)

Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia
por: Krieger, Ekaterina, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in South Korea
por: Lee, Kwangmin, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis
por: Malijan, Greco Mark B., et al.
Publicado: (2022)

Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chattogram Metropolitan Area, Bangladesh
por: Ara, Jahan, et al.
Publicado: (2022)

Mental health needs and services in the West Bank, Palestine
por: Marie, Mohammad, et al.
Publicado: (2016)

A simple rule for interpreting COVID-19 antibody test results, by seroprevalence and vaccination status
por: Chen, Yi-Hsuan, et al.
Publicado: (2022)

The repeated setbacks of HIV vaccine development laid the groundwork for SARS-CoV-2 vaccines
por: Harris, Jeffrey E.
Publicado: (2022)

Anti-SARS-CoV-2 antibodies among vaccinated healthcare workers: Repeated cross-sectional study
por: Mishra, Sanjeeb Kumar, et al.
Publicado: (2022)

1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19
por: Patel, M., et al.
Publicado: (2021)

Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21
por: Anda, Erik Eik, et al.
Publicado: (2022)

Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022
por: Yamayoshi, Seiya, et al.
Publicado: (2022)

Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated Population
por: Quach, Huy Quang, et al.
Publicado: (2022)

Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies Among Vaccinated Populations
por: Demmer, Ryan T., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020
por: McCulloch, Denise J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njfr4dsa17tbmu505o73a5kb56